Jaclyn Beca

1.2k total citations
58 papers, 691 citations indexed

About

Jaclyn Beca is a scholar working on Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jaclyn Beca has authored 58 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Economics and Econometrics, 28 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jaclyn Beca's work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Economic and Financial Impacts of Cancer (19 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Jaclyn Beca is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (26 papers), Economic and Financial Impacts of Cancer (19 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Jaclyn Beca collaborates with scholars based in Canada, United Kingdom and United States. Jaclyn Beca's co-authors include Jeffrey S. Hoch, Kelvin Chan, Jean Hai Ein Yong, Wei Fang Dai, Scott Gavura, Wanrudee Isaranuwatchai, Murray Krahn, T. McGowan, Padraig Warde and Craig C. Earle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Jaclyn Beca

52 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaclyn Beca Canada 15 284 251 204 101 83 58 691
Laura H. Hendrix United States 15 313 1.1× 149 0.6× 273 1.3× 97 1.0× 92 1.1× 39 733
Ryan McCabe United States 12 401 1.4× 126 0.5× 180 0.9× 89 0.9× 92 1.1× 34 707
Christine M. Bestvina United States 13 495 1.7× 243 1.0× 315 1.5× 105 1.0× 109 1.3× 65 966
Joan Prades Spain 8 229 0.8× 87 0.3× 103 0.5× 43 0.4× 97 1.2× 21 458
Helmneh M. Sineshaw United States 19 643 2.3× 163 0.6× 400 2.0× 208 2.1× 93 1.1× 42 1.1k
Junaid Nabi United States 12 205 0.7× 82 0.3× 202 1.0× 76 0.8× 65 0.8× 52 586
W.K. Evans Canada 10 253 0.9× 160 0.6× 200 1.0× 49 0.5× 99 1.2× 31 538
Noam A. VanderWalde United States 16 269 0.9× 104 0.4× 242 1.2× 98 1.0× 103 1.2× 48 822
Joan S. McClure United States 13 499 1.8× 148 0.6× 209 1.0× 162 1.6× 114 1.4× 25 809
Julie Torode United Kingdom 10 365 1.3× 255 1.0× 105 0.5× 59 0.6× 89 1.1× 31 668

Countries citing papers authored by Jaclyn Beca

Since Specialization
Citations

This map shows the geographic impact of Jaclyn Beca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaclyn Beca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaclyn Beca more than expected).

Fields of papers citing papers by Jaclyn Beca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaclyn Beca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaclyn Beca. The network helps show where Jaclyn Beca may publish in the future.

Co-authorship network of co-authors of Jaclyn Beca

This figure shows the co-authorship network connecting the top 25 collaborators of Jaclyn Beca. A scholar is included among the top collaborators of Jaclyn Beca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaclyn Beca. Jaclyn Beca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Wei Fang, Ruth Croxford, Wanrudee Isaranuwatchai, et al.. (2023). Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization. Cancer Medicine. 12(10). 11451–11461. 3 indexed citations
2.
3.
4.
5.
6.
Beca, Jaclyn, Kelvin Chan, David Naimark, & Petros Pechlivanoglou. (2021). Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study. BMC Medical Research Methodology. 21(1). 282–282. 7 indexed citations
7.
Dai, Wei Fang, Maureen Trudeau, Rebecca E. Mercer, et al.. (2020). Impact of rarity on Canadian oncology health technology assessment and funding. International Journal of Technology Assessment in Health Care. 36(4). 404–409. 4 indexed citations
8.
Clausen, Marc, Chloe Mighton, Wei Fang Dai, et al.. (2020). Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives. CMAJ Open. 8(4). E772–E778. 7 indexed citations
9.
Beca, Jaclyn, Andrea Eisen, Erin B. Kennedy, et al.. (2019). Impact of a Novel Prioritization Framework on Clinician-Led Oncology Drug Submissions. Current Oncology. 26(2). 155–161. 2 indexed citations
10.
Beca, Jaclyn, et al.. (2019). A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis. PharmacoEconomics. 37(12). 1525–1536. 11 indexed citations
11.
Beca, Jaclyn, Don Husereau, Kelvin Chan, Neil Hawkins, & Jeffrey S. Hoch. (2017). Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment. PharmacoEconomics. 36(1). 7–15. 11 indexed citations
12.
Beca, Jaclyn. (2016). METHOD MATTERS: PARTITIONED SURVIVAL MODELS CHARACTERIZE AND EXTRAPOLATE RISKS DIFFERENTLY FROM MARKOV MODELS. 1 indexed citations
13.
14.
Beca, Jaclyn, et al.. (2015). Economic Evaluation of Hormonal Therapies for Postmenopausal Women with Estrogen Receptor–Positive Early Breast Cancer in Canada. Current Oncology. 22(2). 84–96. 15 indexed citations
15.
Beca, Jaclyn & Jeffrey S. Hoch. (2014). Exploring the impact of structural uncertainty in partitioned survival models for oncology. Value in Health. 17(3). A205–A206. 7 indexed citations
16.
Beca, Jaclyn, et al.. (2013). Introduction to Cost-Effectiveness Analysis for Clinicians. 90(3). 103–105. 22 indexed citations
17.
Yong, Jean Hai Ein, Jaclyn Beca, & Jeffrey S. Hoch. (2013). The Evaluation and Use of Economic Evidence to Inform Cancer Drug Reimbursement Decisions in Canada. PharmacoEconomics. 31(3). 229–236. 20 indexed citations
18.
19.
Yong, Jean Hai Ein, Jaclyn Beca, Sandra E. Black, et al.. (2012). Genetic Testing in Combination with Preventive Donepezil Treatment for Patients with Amnestic Mild Cognitive Impairment. Molecular Diagnosis & Therapy. 16(6). 389–399. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura H. Hendrix Breakdown of academic impact, for papers by Ryan McCabe Breakdown of academic impact, for papers by Christine M. Bestvina Breakdown of academic impact, for papers by Joan Prades Breakdown of academic impact, for papers by Helmneh M. Sineshaw Breakdown of academic impact, for papers by Junaid Nabi Breakdown of academic impact, for papers by W.K. Evans Breakdown of academic impact, for papers by Noam A. VanderWalde Breakdown of academic impact, for papers by Joan S. McClure Breakdown of academic impact, for papers by Julie Torode
Rankless by CCL
2026